News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
485,115 Results
Type
Article (8058)
Company Profile (140)
Press Release (477012)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166770)
Career Advice (305)
Deals (25739)
Drug Delivery (7)
Drug Development (52878)
Employer Resources (14)
FDA (9762)
Job Trends (8576)
News (238216)
Policy (17909)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (6)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (488)
Accelerated approval (24)
ADA (18)
Adcomms (1)
Allergies (97)
Alliances (33165)
ALS (105)
Alzheimer's disease (980)
Antibody-drug conjugate (ADC) (272)
Approvals (10393)
Artificial intelligence (323)
ASCO (159)
Autoimmune disease (208)
Automation (28)
Bankruptcy (263)
Best Places to Work (6963)
BIO (36)
Biologics (2)
BIOSECURE Act (1)
Biosimilars (112)
BioSpace Insights (17)
Biotechnology (88)
Bladder cancer (139)
Brain cancer (29)
Breast cancer (515)
Cancer (3687)
Cardiovascular disease (221)
Career advice (246)
Career pathing (1)
CAR-T (175)
CDMO (7)
Celiac Disease (1)
Cell therapy (479)
Cervical cancer (34)
Clinical research (47933)
Collaboration (1254)
Commercialization (3)
Compensation (1483)
Complete response letters (34)
COVID-19 (759)
CRISPR (64)
C-suite (761)
Cystic fibrosis (85)
Data (5721)
Denatured (4)
Depression (102)
Dermatology (63)
Diabetes (344)
Diagnostics (4193)
Digital health (39)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (156)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (164)
Earnings (73740)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (87763)
Executive appointments (707)
FDA (12428)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (18)
Frontotemporal dementia (23)
Funding (928)
Gene editing (126)
Generative AI (9)
Gene therapy (322)
GLP-1 (291)
Government (956)
Grass and pollen (2)
Guidances (281)
Healthcare (9343)
Hematology (94)
HIV (53)
Huntington's disease (22)
IgA nephropathy (64)
Immunology and inflammation (98)
Immuno-oncology (59)
Indications (157)
Infectious disease (947)
Inflammatory bowel disease (126)
Inflation Reduction Act (4)
Influenza (84)
Intellectual property (258)
Interviews (42)
IPO (12389)
IRA (2)
Job creations (1970)
Job search strategy (235)
JPM (1)
Kidney cancer (16)
Layoffs (60)
Legal (5209)
Licensing (11)
Liver cancer (44)
Longevity (18)
Lung cancer (514)
Lymphoma (253)
Machine learning (27)
Management (3)
Manufacturing (539)
Marketing (8)
MASH (118)
Medical device (8664)
Medtech (8811)
Mergers & acquisitions (14392)
Metabolic disorders (709)
mRNA (59)
Multiple sclerosis (103)
NASH (4)
Neurodegenerative disease (220)
Neuropsychiatric disorders (40)
Neuroscience (1835)
NextGen: Class of 2026 (3158)
Non-profit (848)
Obesity (225)
Opinion (12)
Ovarian cancer (161)
Pain (172)
Pancreatic cancer (202)
Parkinson's disease (201)
Partnered (12)
Patents (480)
Patient recruitment (514)
Peanut (31)
People (41293)
Pharmaceutical (30)
Pharmacy benefit managers (8)
Phase 1 (15481)
Phase 2 (21403)
Phase 3 (14430)
Pipeline (7448)
Policy (18)
Postmarket research (1572)
Preclinical (6542)
Press Release (34)
Prostate cancer (191)
Psychedelics (7)
Radiopharmaceuticals (189)
Rare diseases (577)
Real estate (3022)
Recruiting (6)
Regulatory (14879)
Reports (21)
Research institute (583)
Resumes & cover letters (46)
Rett syndrome (42)
RNA editing (5)
RSV (48)
Schizophrenia (101)
Series A (158)
Series B (122)
Service/supplier (5)
Sickle cell disease (63)
Spinal muscular atrophy (88)
Sponsored (5)
Startups (2023)
Stomach cancer (3)
Supply chain (50)
Vaccines (331)
Venture capital (17)
Weight loss (73)
Women's health (82)
Date
Today (94)
Last 7 days (279)
Last 30 days (1550)
Last 365 days (19005)
2026 (12673)
2025 (19270)
2024 (22998)
2023 (26554)
2022 (34597)
2021 (37170)
2020 (33473)
2019 (23257)
2018 (17475)
2017 (18770)
2016 (17917)
2015 (24271)
2014 (21685)
2013 (18135)
2012 (20223)
2011 (20441)
2010 (20332)
Location
Africa (229)
Alabama (74)
Alaska (2)
Arizona (306)
Arkansas (11)
Asia (17925)
Australia (2103)
California (12070)
Canada (3175)
China (530)
Colorado (488)
Connecticut (414)
Delaware (208)
Europe (24661)
Florida (1808)
Georgia (386)
Hawaii (3)
Idaho (46)
Illinois (708)
India (51)
Indiana (317)
Iowa (15)
Japan (412)
Kansas (101)
Kentucky (31)
Louisiana (27)
Maine (26)
Maryland (1208)
Massachusetts (7942)
Michigan (308)
Minnesota (563)
Mississippi (4)
Missouri (82)
Montana (20)
Nebraska (11)
Nevada (117)
New Hampshire (60)
New Jersey (2637)
New Mexico (12)
New York (2835)
North Carolina (1293)
North Dakota (4)
Northern California (6057)
Ohio (281)
Oklahoma (14)
Oregon (18)
Pennsylvania (2266)
Puerto Rico (20)
Rhode Island (30)
South America (407)
South Carolina (77)
South Dakota (1)
Southern California (5012)
Tennessee (122)
Texas (1958)
United States (39203)
Utah (363)
Vermont (1)
Virginia (155)
Washington D.C. (38)
Washington State (933)
West Virginia (1)
Wisconsin (74)
Wyoming (1)
485,115 Results for "verastem inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pancreatic cancer
Verastem deprioritizes pancreatic cancer work after ‘decent, but not great’ data shadowed by Revolution
Following the mid-stage readout, Verastem Oncology has decided to move away from its investigational pancreatic cancer drug combo, instead putting resources behind its KRAS inhibitor pill for solid tumors.
June 18, 2026
·
1 min read
·
Tristan Manalac
Press Releases
Verastem Oncology Reports Second Quarter 2026 Financial Results and Highlights Recent Business Updates
August 7, 2026
·
19 min read
Press Releases
Verastem Oncology to Report Second Quarter 2026 Financial Results on August 6, 2026
July 23, 2026
·
1 min read
Press Releases
Verastem Oncology to Present at Jefferies Healthcare Conference 2026
May 27, 2026
·
1 min read
Press Releases
Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - July 2, 2026
July 2, 2026
·
1 min read
Press Releases
Verastem Oncology Appoints Michael P. Bailey to its Board of Directors
May 26, 2026
·
3 min read
Press Releases
Verastem Oncology to Present at Upcoming May 2026 Investor Conferences
May 12, 2026
·
1 min read
Press Releases
Verastem Oncology to Report First Quarter 2026 Financial Results on May 7, 2026
April 23, 2026
·
1 min read
Press Releases
Verastem Oncology Reports First Quarter 2026 Financial Results and Highlights Recent Business Updates
May 8, 2026
·
19 min read
Press Releases
Verastem Oncology Doses First Patient in TARGET-D 202 Phase 2 Registration-Directed Trial of VS-7375 for KRAS G12D-Mutated Advanced Non-Small Cell Lung Cancer
July 23, 2026
·
10 min read
1 of 48,512
Next
